Clinical Trial Update: Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19 [NA]

View source ↗

Summary

This completed clinical trial investigated whether SARS-CoV-2 persists in the olfactory mucosa of patients with prolonged COVID-19 symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Disorder

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: SARS-CoV-2 Infection, Cognitive Disorder | NA | Status: COMPLETED